Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Nrc Health (NRC) EBIAT (2016 - 2026)

Nrc Health's EBIAT history spans 16 years, with the latest figure at $1.8 million for Q4 2025.

  • On a quarterly basis, EBIAT fell 72.59% to $1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.6 million, a 53.19% decrease, with the full-year FY2025 number at $11.6 million, down 53.19% from a year prior.
  • EBIAT hit $1.8 million in Q4 2025 for Nrc Health, down from $4.1 million in the prior quarter.
  • Over the last five years, EBIAT for NRC hit a ceiling of $9.7 million in Q3 2021 and a floor of -$106000.0 in Q2 2025.
  • Historically, EBIAT has averaged $6.8 million across 5 years, with a median of $7.1 million in 2023.
  • Biggest five-year swings in EBIAT: surged 33.38% in 2023 and later plummeted 101.72% in 2025.
  • Tracing NRC's EBIAT over 5 years: stood at $9.6 million in 2021, then plummeted by 31.06% to $6.6 million in 2022, then soared by 33.38% to $8.9 million in 2023, then dropped by 25.94% to $6.6 million in 2024, then crashed by 72.59% to $1.8 million in 2025.
  • Business Quant data shows EBIAT for NRC at $1.8 million in Q4 2025, $4.1 million in Q3 2025, and -$106000.0 in Q2 2025.